The effect of anesthesia on apgar score and maternal hemodynamic parameters after cesarea
Not Applicable
- Conditions
- caesarean.Delivery by elective caesarean section
- Registration Number
- IRCT201503166808N6
- Lead Sponsor
- Birjand University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 84
Inclusion Criteria
ASA Class 1 and 2; candidate for elective cesarean section; fetus is normal and full term.
Exclusion criteria: drug use by the mother; prolonged surgery; fetal abnormalities
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Apgar score. Timepoint: First and fifth minute Apgar score. Method of measurement: Apgar test.;Blood pressure. Timepoint: before induction of anesthesia, after intubation for 12 minutes once every 3 minutes. Method of measurement: Blood pressure device.;Pulse. Timepoint: before induction of anesthesia, after intubation for 12 minutes once every 3 minutes. Method of measurement: Monitoring device.;Oxygen saturation. Timepoint: before induction of anesthesia, after intubation for 12 minutes once every 3 minutes. Method of measurement: Pulse oximeter.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which propofol and thiopental affect maternal hemodynamics during cesarean section?
How does the combination of propofol and thiopental compare to standard anesthetic protocols in terms of neonatal Apgar scores?
Are there specific biomarkers that can predict maternal response to propofol or thiopental in cesarean anesthesia?
What are the potential adverse events associated with propofol and thiopental use in IRCT201503166808N6, and how are they managed?
How do propofol and thiopental compare to other induction agents like etomidate in maternal and neonatal outcomes during cesarean section?